01 6Blake Cassels & Graydon LLP
02 15Janssen Inc.
03 7Paladin Labs Inc.
04 28Paladin Pharma Inc.
01 132154424
02 102464578
03 132572147
04 52595954
05 82680771
06 72683779
01 29TAPENTADOL HYDROCHLORIDE
02 15Tapentadol Hydrochloride
03 12tapentadol hydrochloride
01 4TABLET
02 8TABLET
03 44TABLET (EXTENDED-RELEASE)
01 132015-07-21
02 102022-10-22
03 132025-06-27
04 52026-02-06
05 82028-03-10
06 72028-04-21
Patent Expiration Date : 2015-07-21
Date Granted : 2008-04-15
Brand Name : NUCYNTA CR
Patent Number : 2154424
Filing Date : 1995-07-21
Strength per Unit : 200 mg
Dosage Form : TABLET (EXTENDED-RELEASE)
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2015-07-21
Date Granted : 2008-04-15
Patent Expiration Date : 2015-07-21
Date Granted : 2008-04-15
Brand Name : NUCYNTA CR
Patent Number : 2154424
Filing Date : 1995-07-21
Strength per Unit : 250 mg
Dosage Form : TABLET (EXTENDED-RELEASE)
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2015-07-21
Date Granted : 2008-04-15
Patent Expiration Date : 2025-06-27
Date Granted : 2012-10-30
Brand Name : NUCYNTA CR
Patent Number : 2572147
Filing Date : 2005-06-27
Strength per Unit : 50 mg
Dosage Form : TABLET (EXTENDED-RELEASE)
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2025-06-27
Date Granted : 2012-10-30
Patent Expiration Date : 2015-07-21
Date Granted : 2008-04-15
Brand Name : NUCYNTA CR
Patent Number : 2154424
Filing Date : 1995-07-21
Strength per Unit : 50 mg
Dosage Form : TABLET (EXTENDED-RELEASE)
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2015-07-21
Date Granted : 2008-04-15
Patent Expiration Date : 2022-10-22
Date Granted : 2011-10-11
Brand Name : NUCYNTA CR
Patent Number : 2464578
Filing Date : 2002-10-22
Strength per Unit : 50 mg
Dosage Form : TABLET (EXTENDED-RELEASE)
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-10-22
Date Granted : 2011-10-11
Patent Expiration Date : 2025-06-27
Date Granted : 2012-10-30
Brand Name : NUCYNTA CR
Patent Number : 2572147
Filing Date : 2005-06-27
Strength per Unit : 100 mg
Dosage Form : TABLET (EXTENDED-RELEASE)
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2025-06-27
Date Granted : 2012-10-30
Patent Expiration Date : 2015-07-21
Date Granted : 2008-04-15
Brand Name : NUCYNTA CR
Patent Number : 2154424
Filing Date : 1995-07-21
Strength per Unit : 100 mg
Dosage Form : TABLET (EXTENDED-RELEASE)
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2015-07-21
Date Granted : 2008-04-15
Patent Expiration Date : 2022-10-22
Date Granted : 2011-10-11
Brand Name : NUCYNTA CR
Patent Number : 2464578
Filing Date : 2002-10-22
Strength per Unit : 100 mg
Dosage Form : TABLET (EXTENDED-RELEASE)
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-10-22
Date Granted : 2011-10-11
Patent Expiration Date : 2025-06-27
Date Granted : 2012-10-30
Brand Name : NUCYNTA CR
Patent Number : 2572147
Filing Date : 2005-06-27
Strength per Unit : 150 mg
Dosage Form : TABLET (EXTENDED-RELEASE)
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2025-06-27
Date Granted : 2012-10-30
Patent Expiration Date : 2015-07-21
Date Granted : 2008-04-15
Brand Name : NUCYNTA CR
Patent Number : 2154424
Filing Date : 1995-07-21
Strength per Unit : 150 mg
Dosage Form : TABLET (EXTENDED-RELEASE)
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2015-07-21
Date Granted : 2008-04-15
LOOKING FOR A SUPPLIER?
